In-house R&D approval: companies must show defined R&D programs, DSIR recognition and separate audited R&D accounts. Companies applying for approval of the Prescribed Authority must have well defined, documented R&D programmes, valid DSIR recognition, separate earmarked R&D premises with exclusive R&D staff, and separate audited accounts reporting capital and recurring R&D expenditures; eligibility is confined to biotechnology or manufacturing businesses not producing items specified in the Eleventh Schedule.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
In-house R&D approval: companies must show defined R&D programs, DSIR recognition and separate audited R&D accounts.
Companies applying for approval of the Prescribed Authority must have well defined, documented R&D programmes, valid DSIR recognition, separate earmarked R&D premises with exclusive R&D staff, and separate audited accounts reporting capital and recurring R&D expenditures; eligibility is confined to biotechnology or manufacturing businesses not producing items specified in the Eleventh Schedule.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
